Published Date: 23 Apr 2023
The urgent need to resume child immunizations is highlighted in UNICEF's flagship report.
Read Full News5 Psychiatry Headlines You Missed in September 2026
An updated open-label extension analysis and new MRI data from the phase 3 EPIDYS trial, presented at the 2026 AANEM Annual Meeting, add to the evidence for givinostat's long-term effects on disease progression.
A new Bayesian network meta-analysis found nipocalimab's serious adverse event rates compared favorably with other gMG therapies, while overall adverse event rates were comparable.
New data from a Cure SMA survey showed that children treated with disease-modifying therapy soon after birth walk more often and have fewer comorbidities than those treated later.
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is the history of MDS!
Exocrine Pancreatic Insufficiency Estimated in 40% of Chronic Pancreatitis
Friedman outlines how dermatologists can track cumulative corticosteroid exposure, identify at-risk patients, and improve patient adherence with handouts.
1.
Big Comeback for Myeloma Drug; DIY Cancer Therapy; Gut Clues to Bladder Cancer
2.
EVP Beats Cisplatin for Resectable MIBC
3.
For elderly, unfit patients, the all-oral AML regimen shows promise.
4.
Study sets benchmark for treatment of advanced cervical cancer
5.
For cancer patients who are not responding to chemotherapy, new genes and natural toxins offer hope.
1.
Case-Based Learning on Adaptive Management of Oligometastatic Disease Across Treatment Phases
2.
The Link Between Being Overweight and Cancer
3.
Uncovering the Mysteries of the RDW Blood Test
4.
Vaso Occlusive Crisis: Understanding the Painful Reality of Sickle Cell Disease
5.
Optimizing the Diagnosis and Treatment of Hematological Diseases Through Artificial Intelligence
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
1.
Common Cancer Myths Debunked
2.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
3.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VI
5.
Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation